Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
Opzelura by Incyte for Vulvar Lichen Sclerosus: Likelihood of Approval
Opzelura is under clinical development by Incyte and currently in Phase II for Vulvar Lichen Sclerosus. According to GlobalData, Phase...
Opzelura by Incyte for Seborrhea: Likelihood of Approval
Opzelura is under clinical development by Incyte and currently in Phase II for Seborrhea. According to GlobalData, Phase II drugs...
Opzelura by Incyte for Hidradenitis Suppurativa: Likelihood of Approval
Opzelura is under clinical development by Incyte and currently in Phase II for Hidradenitis Suppurativa. According to GlobalData, Phase II...
Opzelura by Incyte for Hand Dermatitis: Likelihood of Approval
Opzelura is under clinical development by Incyte and currently in Phase II for Hand Dermatitis. According to GlobalData, Phase II...
Opzelura by Incyte for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid Lupus Erythematosus (DLE): Likelihood of Approval
Opzelura is under clinical development by Incyte and currently in Phase II for Chronic Cutaneous Lupus Erythematosus (CCLE) / Discoid...
Opzelura by Incyte for Graft Versus Host Disease (GVHD): Likelihood of Approval
Opzelura is under clinical development by Incyte and currently in Phase II for Graft Versus Host Disease (GVHD). According to...